Chinese Traditional and Herbal Drugs
|
2025, 56(15): 5508-5518
Chemical composition of Changyanning Granules and analysis of its pharmacological effects and metabolomics in improving intestinal mucosal injury
Full
WANG Jia1, FU Rui2, ZHAO Haiyu2, RONG Yan2, LI Liang2, CHEN Yunxin2, CHEN Lihua2, WANG Huijun2, HOU Hongping2, WEI Xiaolu2
Affiliations
1 Hainan Huluwa Pharmaceutical Group Co., Ltd., Haikou 570200, China; 2 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
About Author:
北京市自然科学基金资助项目 (7254509)
doi: 10.7501/j.issn.0253-2670.2025.15.016
Outline
Objective To explore the components of Changyanning Granules (肠炎宁颗粒) and their pharmacological effects on aspirin-induced intestinal mucosal injury in rats, as well as the molecular synergistic mechanism of metabolomics. Methods The chemical components of Changyanning Granules were identified using UPLC-LTQ-Orbitrap-MS method. Thirty-six SD rats were randomly divided into control group, model group, positive group (omeprazole 2.08 mg/kg + rebamipide 31.25 mg/kg), high-, medium-, and low-dose (0.96, 0.48, 0.24 g/kg) of Changyanning Granules. Aspirin was used to induce intestinal mucosal injury in rats. After drug intervention, the activities of diamine oxidase (DAO) and lysozyme (LZM) in serum of rats in each group were detected; The levels of inflammatory factors in serum, stomach and small intestine tissues were detected; Hematoxylin eosin (HE) staining was used to observe the pathological changes in stomach and small intestine tissues. Differential metabolites were screened based on metabolomics for metabolic pathway analysis. Results A total of 52 compounds were identified in Changyanning Granules, mainly composed of flavonoids and organic acids. Compared with control group, DAO activity in serum of rats in model group was significantly increased (P < 0.001), and LZM activity was significantly decreased (P < 0.001). The levels of pro-inflammatory cytokines interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in serum, stomach and small intestine tissues were significantly increased (P < 0.05, 0.01, 0.001), levels of anti-inflammatory factors IL-4 and IL-10 were significantly decreased (P < 0.05, 0.01, 0.001). Damages were observed in stomach and small intestine tissues. Compared with model group, DAO activity in serum of rats in Changyanning Granules groups was significantly reduced (P < 0.05, 0.01), and LZM activity was significantly increased (P < 0.05, 0.01). The levels of IL-1β, IL-6 and TNF-α in serum, stomach and small intestine tissues were significantly reduced (P < 0.05, 0.01, 0.001), and levels of IL-4 and IL-10 were significantly increased (P < 0.05, 0.01, 0.001). The damage to the stomach and small intestine tissues was alleviated. Metabolomics results showed that there were a total of 33 differential metabolites involved in multiple metabolic pathways after intervention with Changyanning Granules. Conclusion Changyanning Granules are mainly composed of flavonoids and organic acids. Changyanning Granules significantly improve aspirin-induced intestinal mucosal injury in rats by regulating DAO, LZM and inflammatory factors. Metabolomics confirms that it works synergistically through multiple pathways (amino acid metabolism such as phenylalanine, phosphatase metabolism), providing a basis for the treatment of intestinal mucosal injury.
Changyanning Granules
/
intestinal mucosal damage
/
inflammatory factors
/
metabonomics
/
phenylalanine, tyrosine and tryptophan biosynthesis
/
lysine, leucine and testosterone biosynthesis
/
phosphatase metabolism
王家, 符蕤, 赵海誉, 荣妍, 李亮, 陈韵心, 陈丽华, 王慧君, 侯红平, 魏晓露.
肠炎宁颗粒的化学成分及改善肠黏膜损伤的药效和代谢组学分析.
中草药,
2025
, 56
(15)
: 5508
-5518
.
DOI: 10.7501/j.issn.0253-2670.2025.15.016
WANG Jia, FU Rui, ZHAO Haiyu, RONG Yan, LI Liang, CHEN Yunxin, CHEN Lihua, WANG Huijun, HOU Hongping, WEI Xiaolu.
Chemical composition of Changyanning Granules and analysis of its pharmacological effects and metabolomics in improving intestinal mucosal injury[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(15)
: 5508
-5518
.
DOI: 10.7501/j.issn.0253-2670.2025.15.016
Year 2025 volume 56 Issue 15
44
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.15.016
- Receive Date:2025-04-17
- Online Date:2026-11-12